Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.81 - $12.62 $12,311 - $15,838
1,255 Added 230.28%
1,800 $20,000
Q1 2023

May 12, 2023

SELL
$8.79 - $14.58 $439 - $729
-50 Reduced 8.4%
545 $5,000
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $25,955 - $30,835
-2,259 Reduced 79.15%
595 $7,000
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $25,502 - $66,623
2,055 Added 257.2%
2,854 $35,000
Q2 2022

Aug 15, 2022

BUY
$19.63 - $26.62 $15,684 - $21,269
799 New
799 $16,000
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $33,112 - $41,640
-1,134 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$27.85 - $34.49 $31,581 - $39,111
1,134 New
1,134 $33,000
Q4 2020

Feb 12, 2021

SELL
$27.53 - $33.79 $981,719 - $1.2 Million
-35,660 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$21.1 - $29.13 $752,426 - $1.04 Million
35,660 New
35,660 $996,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.